Spermosens AB (NGM: SPERM)

Market Cap	4.54M
Revenue (ttm)	n/a
Net Income (ttm)	-9.74M
Shares Out	283.61M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,390,363
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0104 - 0.8350
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Spermosens AB

Spermosens AB provides diagnostic health care products and services in Sweden. The company offers male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB was incorporated in 2018 and is based in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2018
• Employees: 7
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: SPERM